Status:
UNKNOWN
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
COVID19
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a significant threat to global health. As the disease progresses, a series of acute com...
Detailed Description
The aim of this study is to investigate the predictive role of cardiac biomarkers and significant pulmonary complications for late infection complications COVID-19 coronavirus on the heart and lung in...
Eligibility Criteria
Inclusion
- positive test for covid19
- high ultrasensitive troponin
- pulmonary damage \> 25%
- no cardiac or lung known disease
- Consent inform signed
Exclusion
- intensive care and mechanical ventilation needs
- chronic inflammatory disease
- active neoplasm
- use of immunosuppressant
- renal failure
- pregnant woman
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04353245
Start Date
June 1 2020
End Date
September 30 2021
Last Update
April 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração - Hospital das Clínicas - Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil